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Abstract
Auto-transplantation of adipose tissue is commonly 
used for the treatment of tissue defects in plastic 
surgery. The survival of the transplanted adipose tis-
sue is not always constant, and one of reasons is the 
accelerated apoptosis of the implanted preadipocytes. 
We have recently established highly homogeneous 
preadipocytes, named ccdPAs. The aim of the current 
study was to evaluate the regulation of the potency of 
platelet-rich plasma (PRP) on the apoptosis of ccdPAs 
in vitro. PRP stimulated the proliferation of the pre-
adipocytes in a dose-dependent manner, and the stim-
ulatory activity of 2% PRP was significantly higher than 
that of 2% FBS or 2% platelet-poor plasma (PPP). The 
presence of 2% PRP significantly inhibited serum star-
vation- or TNF-α/cycloheximide-induced apoptosis in 
comparison to 2% FBS or 2% PPP. DAPK1 and Bcl-2-in-
teracting mediator of cell death (BIM) mRNAs were re-
duced in the preadipocytes cultured with 2% PRP in 
comparison to those cultured in 2% FBS. The gene ex-
pression levels were significantly higher in cells cul-
tured without serum in comparison to cells cultured 
with 2% FBS, and the levels in the cells with 2% PRP 
were reduced to 5-10% of those in the cells without 
serum. These results indicated that ccdPAs exhibit an-
ti-apoptotic activities, in addition to increased pro-
liferation, when cultured in 2% PRP in comparison to 
the same concentration of FBS, and that this was ac-
companied with reduced levels of DAPK1 and BIM 
mRNA expression in in vitro culture. PRP may improve 
the outcome of transplantation of adipose tissue by en-
hancing the anti-apoptotic activities of the implanted 
preadipocytes.
Keywords: adipocytes; apoptosis; Bcl-2-like protein 
11;  death-associated  protein  kinase;  platelet-rich 
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Introduction
Aspirated fat is a common source of autologous tis-
sue transplantation for the correction of tissue defects 
in plastic and reconstructive surgery (Billings and 
May, 1989; Patrick, 2000, 2001). Aspirated fat con-
tains multipotential preadipocytes and progenitor 
cells, which have been utilized as a source of 
cell-based regenerative medicine (Stashower et al., 
1999; Zuk et al., 2001; Gimble et al., 2007; 
Yoshimura et al., 2009; Bauer-Kreisel et al., 2010; 
Sterodimas et al., 2010). Although several different 
techniques of fat grafting have been developed, 
the outcomes of the transplantation vary widely. 
The most important factor required for successful 
grafting is to optimize the survival of the trans-
planted preadipocytes and other cells in the graft. 
In previous studies, we and others have shown 
that various cytokines are involved in the efficient 
cell survival of the implants (Kimura et al., 2003; PRP prevents apoptosis of adipocytes    331
Figure 1. The effects of platelet-rich plasma (PRP) on the 3-dimensional 
culture of ccdPAs. 100 μl of fibrin gels containing 1 × 10
7 cells/ml of 
ccdPAs (FG/ccdPAs) were formed in cell culture insert and incubated in 
DMEM/HAM with 10% FBS for 16 hrs. The medium was replaced by 
DMEM/HAM in the presence or absence of different concentrations of 
FBS or PRP. (A) Photographs of FG/ccdPAs in the inserts were taken af-
ter 24 hr of culture. (B) The culture supernatant was collected from each 
well and the LDH activities expressed by the fluorescence of resorufin 
generated by coupled enzymatic reaction were examined. *P ＜ 0.05.
Yamaguchi  et al., 2005; Cho et al., 2006; 
Torio-Padron et al., 2007; Kuramochi et al., 2008; 
Ning et al., 2009).
    Platelet rich plasma (PRP) (Eppley et al., 2006; 
Foster et al., 2009; Redler et al., 2011) has been 
widely applied for practical medicine, such as aes-
thetic plastic surgery and the treatment of soft-tis-
sue ulcers (Welsh, 2000; Man et al., 2001; Margolis 
et al., 2001; Bhanot and Alex, 2002; Martinez-Zapata 
et al., 2009; Sclafani, 2009). Once activated, plate-
lets secrete various bioactive cytokines, including pla-
telet-derived growth factor (PDGF) and trans-
forming growth factor beta 1 (TGF-β1), which in-
crease angiogenesis and cell proliferation relevant 
to soft tissue regeneration. PRP has been applied 
for fat grafting, and in fact, has been shown to im-
prove the survival of implanted adipose tissue in 
patients (Abuzeni and Alexander, 2001; Sadati et 
al., 2006; Cervelli et al., 2009). Thus, the use of 
PRP has been broadened to the tissue-engineer-
ing field using adipose tissue-derived multi-poten-
tial cells (Anitua et al., 2006; Muller et al., 2009). 
PRP is also expected to function as an autologous 
fibrin-based scaffold for transplanted cells (Anitua 
et al., 2006; Wu et al., 2009; Kang et al., 2011). In 
fact, recent our study showed that fibrin-based 
scaffold decreased the apoptotic cell death of mur-
ine ccdPAs in mice transplantation model (Aoyagi 
et al., 2011).
        We have recently identified proliferative pre-
adipocytes, ceiling culture-derived proliferative adi-
pocytes (ccdPAs), as homogeneous cells suitable 
for ex vivo gene therapy applications via autolo-
gous transplantation (Asada et al., 2011; Kuroda et 
al., 2011). The ccdPAs are characterized by their 
high proliferative capacity with spontaneous adipo-
genic potential in scaffold fibrin gel culture (Aoyagi 
et al., 2012). The establishment of a highly homo-
genous preadipocyte line made it possible to per-
form examinations to identify the optimal scaffolds 
and cytokines that can be used to improve the sur-
vival of transplanted preadipocytes. We herein stud-
ied the effects of PRP, and an autologous cytokine 
cocktail, on the apoptotic properties of preadipocytes 
using the ccdPAs.
Results
PRP inhibits fibrin scaffold gel shrinkage and 
improves the viability of ccdPAs in 3-dimensional 
culture
We have recently established a 3-dimensional (3-D) 
culture system for ccdPAs using fibrin gel (FG) 
(Aoyagi et al., 2012). Using the 3-D culture system, 
the effects of PRP on the gel shrinkage and cell 
viability were analyzed in comparison to FBS. The 
FG/ccdPAs were formed and maintained in culture 
medium containing 10% FBS for 16 hr. The culture 
medium was replaced with fresh medium containing 
2% PRP, 2% FBS or 10% FBS, or with medium 
without serum, and cells were subsequently incubated 
for an additional 24 hr.
    The resulting gel sizes varied among the cultures 
grown in each type of medium. The gels without 
serum or with 2% FBS showed a drastic volume 
reduction, while the volumes of the gels cultured 
with 10% FBS or 2% PRP were not obviously 
reduced (Figure 1A). The culture supernatants were 
collected from each well and LDH activity was 
measured to evaluate the viability of cells. The 
LDH activity significantly decreased in the culture 
medium with 2% PRP in comparison to the 
medium with 2% or 10% FBS (Figure 1B). TUNEL 
staining of the gel sections showed the number of 
apoptotic cells to significantly decrease in the 
medium with 2% PRP in comparison to the medium 
with 2% FBS (1.5 ± 1.1% vs 9.8 ± 1.9%, P ＜ 0.05). 
These results suggested that 2% PRP inhibits the 
shrinkage of FG/ccdPAs gels, and improves the 
cell viability in comparison to the same concentration 
of FBS.332    Exp. Mol. Med. Vol. 44(5), 330-339, 2012
Figure  2. Platelet-rich plasma (PRP) promotes the proliferation of 
ccdPAs. (A) Photographs of ccdPAs were taken after 3 days in culture 
containing DMEM/F12-HAM in the absence of serum (a) or the presence 
of 2% (b) or 10% (c) FBS or 2% (d) PRP. The scale bar indicates 200 
μm. (B) Cells were seeded into 96 well plates and incubated in 
DMEM/F12-HAM containing 20% FBS for 24 hr. The culture medium was 
then replaced with DMEM/F12-HAM in the absence of serum (control) or 
presence of 2% FBS or 10% FBS or 2% PRP. After 3 days in CO2 in-
cubator, the cell number in each well was examined by DNA content in 
comparison to those on day 0 (open bar). The values for the serum (-), 
10% FBS, and 2% PRP groups were significantly different compared with 
those on Day 0 (*P ＜ 0.05). (C) The cell numbers were examined in 
wells cultured in DMEM/F12-HAM containing various concentrations of 
PRP (circle), FBS (triangle), and PPP (square) after 3 days of culture 
similarly as Figure 2B. The growth stimulatory effect was not significantly 
different between 10% and 20% FBS and PPP (data not shown).
PRP has a high proliferation-inducing potential for 
ccdPAs in plate culture
In order to evaluate the function of PRP on cell 
survival in the gel, we next examined the effects of 
PRP on the proliferation of ccdPAs in comparison 
to FBS. The cells (2.5 × 10
5 cells) were seeded 
and incubated with DMEM/HAM containing 20% 
FBS in 10 cm dishes for 16 hr. The media was 
replaced with medium containing 2% PRP, 2% 
FBS, or 10% FBS, and the cells were then cultured 
for 3 days. The cell appearance was not apparently 
changed among the ccdPAs cultured for 3 days in 
plates with media containing 2% PRP, 2% FBS, or 
10% FBS (Figure 2A). To examine the cell 
proliferation, 2 × 10
3 cells of ccdPAs were seeded 
onto 96 well plates and incubated at 37
oC for 24 hr. 
The media was replaced with medium with or 
without 2% PRP, 2% FBS, or 10% FBS (Day 0), 
and the cells were cultured for 3 days. The number 
of cells in each well was evaluated by measuring 
the DNA content. In contrast to the observation that 
the cell numbers on Day 3 were not significantly 
changed in comparison to those at Day 0 in the 
cultures incubated in medium containing 2% FBS, 
the cell numbers were significantly increased in 
cells cultured in the medium with 10% FBS or 2% 
PRP, and notably, the number of cells on Day 3 in 
the medium containing 2% PRP was significantly 
increased in comparison to the cells cultured with 
10% FBS (Figure 1B). The cell numbers in the 
media with various concentrations of PRP showed 
a dose-dependent increase up to 5% PRP; the 
number of cells present in the media with 0.5-1% 
PRP was almost equivalent to that of the cells 
cultured with 5-10% FBS (Figure 2C). These results 
indicated that the proliferation-inducing potential of 
PRP for ccdPAs was higher in comparison to that 
of FBS.
PRP inhibits the apoptosis of ccdPAs 
The high proliferation-inducing property of PRP for 
ccdPAs in culture prompted us to further analyze 
PRP for protective effects against apoptosis in 
ccdPAs, since PRP is rich in cytokines and protei-
nases involved not only in proliferation, but also in 
regulating apoptosis (Eppley et al., 2004, 2006; 
Foster et al., 2009; Redler et al., 2011). The pro-
tection of the cells from death may contribute to 
their longer survival after transplantation, together 
with a high potential for proliferation. To investigate 
the possibility, the ccdPAs (1 × 10
6 cells) were 
seeded and incubated in a 10 cm dish with 
DMEM/HAM medium containing 20% FBS for 16 
hr, and subsequently incubated with the medium 
with or without 2% FBS, 2% PRP, or 2% PPP. After 
incubation for 8 hr, the cells were collected and 
stained with Annexin V-FITC. The flow cytometric 
analysis showed that 5.5% of cells were identified 
as Annexin V positive in the medium without serum 
(Figure 3A). The number of apoptotic cells was sig-
nificantly decreased in the media with 2% FBS, 2% 
PRP, or 2% PPP in comparison to that in the cells 
cultured in serum-free medium. Among the various 
supplements, 2% PRP drastically reduced the num-
ber of apoptotic cells in comparison to 2% FBS or 
2% PPP. ERK1/2 phosphorylation was examined 
to further analyze the protective effect of PRP 
against apoptosis, because the activation of the PRP prevents apoptosis of adipocytes    333
Figure 3. PRP decreased the apoptotic cell death and caspase 3 activity 
induced by TNF-α and cycloheximide in ccdPAs. (A) ccdPAs were seed-
ed and incubated for 16 hr with medium containing 20% FBS, and the 
medium was then replaced with fresh medium without serum (Serum (-)) 
or with media containing 2% PRP, FBS, or PPP, and the cells were sub-
sequently incubated at 37
oC for 8 hr. The cells were then collected, 
stained by Annexin V-FITC and propidium iodide (PI), and analyzed us-
ing a Tali
TM Image Based Cytometer (Life technologies). FITC-positive/ 
PI-negative cells were considered to be apoptotic cells. *P ＜ 0.05. (B) 
After incubation for 16 hr with medium containing 20% FBS, ccdPAs 
were pretreated for 2 hr with the medium containing 2% PRP or FBS. 
The cells were treated with TNF-α and cycloheximide for 5, 30, 60, and 
120 min in the medium with 2% FBS (closed bar) or 2% PRP (open bar). 
Cell lysates were prepared at each time point as well as pretreatment 
(pre) and then were subjected to an immunoblot analysis of phosphory-
lated or unphosphorylated form of ERK1/2, and Actin. Results of densito-
metric analysis of phosphorylated form of ERK2 (pERK2) is shown 
below. After normalization of signals of pERK2 by Actin, each value of 
pERK2 was expressed as the fold increase of that at 5 min with 2% FBS. 
*P ＜ 0.05. (C) After pretreatment for 2 hr with the medium containing 
2% PRP, FBS, or PPP, the cells were incubated for 3 hr in the absence 
(open bars) or presence (closed bars) of TNF-α and cycloheximide, 
which induce apoptotic cell death. The caspase-3 activity in the lysates of 
collected cells were measured. *P ＜ 0.05.
cascade is important for apoptosis via various in-
tracellular signals including TNF-α (Cawthorn and 
Sethi, 2008; Mebratu and Tesfaigzi, 2009; Cagnol 
and Chambard, 2010). The cells were incubated 
with 2% PRP, FBS, or PPP for 2 hr, and apoptosis 
was induced by TNF-α and cycloheximide. Phosphor-
ylation was detected following treatment with 
TNF-α and cycloheximide for 5 min in the cells cul-
tured with 2% FBS. A densitometric analysis 
showed the amount of phosphorylated ERK2, and 
not phosphorylated ERK1, to significantly decrease 
in the medium with 2% PRP in comparison to the 
medium with 2% FBS (Figure 3B). The caspase-3 
activity induced by TNF-α and cycloheximide for 3 
hr were also significantly decreased in ccdPAs in 
the medium with 2% PRP in comparison to the 
cells cultured with 2% FBS or 2% PPP (Figure 3C). 
Thus, the apoptosis of ccdPAs was inhibited by 
culturing them in the medium with 2% PRP in vitro.
PRP almost completely inhibits the expression of the 
pro-apoptotic genes, DAPK1 and BIM, in ccdPAs after 
serum starvation
In order to identify the molecules involved in the 
anti-apoptotic effects of PRP on ccdPAs in culture, 
the expression profiles of representative apoptosis- 
related genes were examined using a PCR array 
profiler. The cells (2.5 × 10
5 cells) were seeded 
into 10 cm dishes and incubated in DMEM/HAM 
containing 20% FBS for 16 hr. The media was 
replaced with DMEM/HAM containing 2% PRP or 
FBS, the cells were incubated for 3 days, and the 
total RNA was isolated from the cultured cells to 
analyze the expression of apoptosis-related genes. 
Two independent experiments showed that, among 
the 84 genes examined, there were 8 genes with a 
more than 2-fold increase in expression, and 9 
genes with a more than 2-fold decrease in expression 
in the cells cultured in the medium with 2% PRP 
compared with those cultured in the medium with 
2% FBS (Table 1). We focused our interest on two 
genes, DAPK1 (reduced to 7.4% of the expression 
level observed with FBS) and BCL2L11 (also called 
BIM, reduced to 18.9% of the level observed with 
FBS), as representative genes with the obvious 
downregulation in the medium with 2% PRP 
(Figure 4). DAPK1 and BIM have been shown to 
be one of master regulators of cell death (Gozuacik 
and Kimchi, 2006), and is essential for BAX- 
dependent cell death (Kim et al., 2009; Ren et al., 
2010), respectively.
    The role of DAPK1 and BIM genes in apoptosis 
of preadipocytes was investigated by examining 
the effect of serum starvation of cells incubated 
with PRP on the expressions of these genes. The 
ccdPAs (2.5 × 10
5 cells) were seeded into 10 cm 
dishes and incubated in DMEM/HAM containing 
20% FBS for 16 hr. The medium was replaced by 
medium containing 10% FBS (control), 2% FBS, 
2% PRP, or 2% PPP, the cells were cultured for 3 
days and the expression of DAPK1 and BIM were 334    Exp. Mol. Med. Vol. 44(5), 330-339, 2012
     Unigene     Refseq     Symbol                           Description Fold change
Downregulated
    Hs.380277
    Hs.469658
    Hs.5353
    Hs.591834
    Hs.513667
    Hs.501497
    Hs.87247
    Hs.710305
    Hs.643120
Upregulated
    Hs.127799
    Hs.462529
    Hs.478275
    Hs.654459
    Hs.522506
    Hs.9216
    Hs.145726
    Hs.194726
NM_004938
NM_006538
NM_001230
NM_003844
NM_003946
NM_001252
NM_003806
NM_004536
NM_000875
NM_001165
NM_003790
NM_003810
NM_001561
NM_021138
NM_001227
NM_001205
NM_004874
DAPK1
BCL2L11
CASP10
TNFRSF10A
NOL3
CD70
HRK
NAIP
IGF1R
BIRC3
TNFRSF25
TNFSF10
TNFRSF9
TRAF2
CASP7
BNIP1
BAG4
Death-associated protein kinase 1
BCL2-like 11 (apoptosis facilitator)
Caspase 10, apoptosis-related cysteine peptidase
Tumor necrosis factor receptor superfamily, member 10a
Nucleolar protein 3 (apoptosis repressor with CARD domain)
CD70 molecule
Harakiri, BCL2 interacting protein (contains only BH3 domain)
NLR family, apoptosis inhibitory protein
Insulin-like growth factor 1 receptor
Baculoviral IAP repeat-containing 3
Tumor necrosis factor receptor superfamily, member 25
Tumor necrosis factor (ligand) superfamily, member 10
Tumor necrosis factor receptor superfamily, member 9
TNF receptor-associated factor 2
Caspase 7, apoptosis-related cysteine peptidase
BCL2/adenovirus E1B 19kDa interacting protein 1
BCL2-associated athanogene 4
13.5803 ↓
  5.2596 ↓
  4.0726 ↓
    3.967   ↓
  2.8887 ↓
  2.8129 ↓
  2.5816 ↓
  2.3876 ↓
  2.1732 ↓
  10.851   ↑ 
  4.0981 ↑
  4.0907 ↑
  2.9875 ↑
  2.8331 ↑
  2.2033 ↑
  2.0258 ↑
  2.0241 ↑
Genes identified as having a change in expression ＞ 2-fold induced by the addition of PRP in comparison to 2% FBS are shown.
Table 1.  Apoptosis-related genes affected by PRP
Figure 4. The results of the analysis of the expression of apoptosis-re-
lated genes affected by PRP. Total RNA was extracted from the cells cul-
tured in the presence of 2% FBS or 2% PRP for 72 hr. The total RNA 
was subjected to cDNA synthesis and subsequent quantification of the 
mRNA expression for various apoptosis-related genes. The fold-changes 
in the quantified mRNA amounts compared to the average value of 
house-keeping genes were plotted for each gene (x-axis; cultured in 2% 
FBS, y-axis; cultured in 2% PRP).
analyzed. The DAPK1 mRNA level was increased 
10.6-fold by serum starvation in comparison to the 
level in the cells cultured with 10% FBS, and the 
mRNA level was decreased to that of 10% FBS by 
the presence of 2% PRP. It is worth noting that, 
although the mRNA levels of DAPK1 in the cells 
cultured with 2% FBS and 2% PPP significantly 
decreased in comparison to those cultured without 
serum, the reductions were by 20.4% and 11.9%, 
respectively, which were less than that (93.6%) 
induced by culture in 2% PRP. The BIM mRNA 
levels were also drastically increased in the cells 
cultured in serum free medium in comparison to 
those cultured in the medium with 10% FBS (Figure 
2C). The mRNA levels were reduced to those 
observed in the cells cultured with 10% FBS by the 
addition of 2% PRP. Again, the potential of 2% 
PRP to inhibit the mRNA expression of the target 
gene (by 87.2%) was significantly higher than that 
of the 2% FBS (54.1%) or 2% PPP (72.2%). Thus, 
PRP almost completely inhibited the expression of 
apoptosis-related genes induced by serum starvation.
Discussion
PRP inhibited the volume reduction of the 3D gels 
embedded with ccdPAs, the homogeneous pre-
adipocytes, in comparison to the same concen-
tration of FBS, and this was accompanied by in-
creased cell viability in the gel. These observations 
prompted us to analyze the effects of PRP on the 
apoptosis and proliferation of the ccdPAs. The re-
sults showed that 2% PRP had a higher inhibitory 
effect on the apoptotic cell death of ccdPAs than 
2% FBS or 2% PPP (Figure 3). A comparison be-
tween 2% PRP and 2% FBS by a gene expression 
profile analysis revealed that PRP downregulated 
11% of the 84 representative apoptosis-related 
genes and upregulated 10% of the 84 representa-
tive apoptosis-related genes (Figure 4 and Table 1). 
The most drastically reduced genes were DAPK1, 
the protein product of which plays important roles 
in a wide range of signal transduction pathways 
with diverse outcomes, such as apoptosis, autoph-PRP prevents apoptosis of adipocytes    335
Figure 5. Serum starvation induced the expression of the DAPK1 and 
BIM genes, which was prevented by culture with 2% PRP. The ccdPAs 
were seeded and incubated for 16 hr in DMEM/HAM containing 20% 
FBS, and the culture medium was then replaced with medium without se-
rum (Serum (-)), or with 2% or 10% FBS, 2% PRP, or 2% PPP, followed 
by incubation for an additional 72 hr. Quantitative reverse tran-
scription-polymerase chain reaction (RT-PCR) was performed to eval-
uate the mRNA expression levels of DAPK1 (A) and BIM (B). The quanti-
fication of the given genes was expressed as relative mRNA level com-
pared with a control after normalization to 18S RNA. *P ＜ 0.05.
agy and immune responses (Lin et al., 2010), and 
BIM, encoding one of the BH3-only proteins, which 
is a critical regulator of apoptosis in many cell 
types (Ramesh et al., 2009). The induction of these 
genes by apoptotic stimuli was almost completely 
prevented in the presence of PRP (Figure 5).
    PRP,  a  concentrate  of  physiological  cytokines, 
has been widely utilized as an injectable material in 
the clinic since the 1970s to enhance soft and hard 
tissue healing (Andia et al., 2010; Lopez-Vidriero et 
al., 2010; Redler et al., 2011; Yu et al., 2011), 
mainly by stimulating cell proliferation and angio-
genesis in the injured tissues. PRP promotes the 
growth of various cells, including tissue-derived 
progenitor cells (Liu et al., 2002; Lucarelli et al., 
2003; Doucet et al., 2005; Frechette et al., 2005; 
Vogel et al., 2006; Kakudo et al., 2008; Kurita et 
al., 2008; Cervelli et al., 2009; Chieregato et al., 
2011), and increases the revascularization of the 
transplanted tissues (Bir et al., 2009). Based on 
these findings, the clinical applications of PRP 
have been broadened to recommend its use as an 
additive to tissue/cell transplantation therapies in 
plastic and reconstructive surgeries, and more re-
cently in regenerative medicine. In fact, PRP has 
been shown to improve the fat graft survival 
(Abuzeni and Alexander, 2001; Sadati et al., 2006; 
Cervelli et al., 2009; Nakamura et al., 2010; Pires 
Fraga et al., 2010; Oh et al., 2011) and bone and 
periodontal regenerations via cell transplantation 
(Tobita et al., 2008; Chen et al., 2010; Yamada et 
al., 2010; Arvidson et al., 2011).
    In order to apply PRP for clinical transplantation 
therapy using preadipocytes cultured in vitro, it is 
necessary to elucidate the effects of PRP on cell 
survival in the grafts. However, the mechanisms by 
which PRP increases graft survival have not been 
well-characterized so far. The current study showed 
that PRP strongly induces the proliferation of 
ccdPAs, preadipocytes which were previously 
shown to be more adipogenic than ASCs (Asada et 
al., 2011), compared with FBS at an equivalent 
concentration. Vogel et al. (2006) described that, 
because the addition of 2% PRP did not result in 
sufficient thrombocyte-clot formation to maintain a 
clot in the medium, a higher concentration of PRP, 
3%, was evaluated for the stimulation of the MSC 
proliferation. In this study, to evaluate the efficacy 
of lower concentrations of PRP, the PRP was 
activated by thrombin to release cytokines 
(Aiba-Kojima et al., 2007) prior to the experiments. 
As a result, 2% PRP showed almost the same 
effects on proliferation as 10% PRP, indicating its 
usability as a substitute for FBS in the expansion of 
preadipocytes for clinical applications. Finally, 2% 
PRP showed anti-apoptotic activities on the 
preadipocytes, providing evidence that it can be used 
as an efficacious additive in the cell transplantation 
cocktail.
    We observed that the expression of the DAPK1 
and BIM genes was substantially upregulated by 
serum starvation in ccdPAs. However, the addition 
of PRP in the growth media effectively inhibited the 
apoptosis and downregulated the expression of 
these genes. TGF-β has been shown to induce the 
expression of DAPK1 and BIM, and to lead to 
subsequent apoptosis in other cell types (Jang et 
al., 2002; Wildey et al., 2003; Ramjaun et al., 2007; 
Yu  et al., 2008). PRP may therefore inhibit the 
TGF-β-induced apoptosis cascade(s) during serum 
starvation in ccdPAs. Further analyses are needed 
to elucidate the mechanism(s) underlying the 
inhibitory potential of PRP on the expression levels 
of the representative apoptotic genes. The gene 
expression analysis also showed that PRP regulated 
the expression levels of genes involved in TNF 
signaling (TNFRSF10A, TNFRSF25, TNFSF10, 
TNFRSF9, and TRAF2), and of the Bcl protein 
superfamily, with its related proteins (HRK, BNIP1, 
and BAG4) (Table 1). The changes in the expression 
of these genes may also improve the survival of 
ccdPAs by modulating the apoptotic stimuli, 
considering that TNF-α signaling plays an important 
role in the regulation of the adipose tissue mass 
(Warne, 2003).
    In conclusion, PRP inhibits cell apoptosis as well 
as or better than FBS, and also promotes the 
proliferation of the ccdPAs. The gene expression 
analyses identified that the DAPK1 and BIM genes 
were the most highly downregulated apoptosis-related 336    Exp. Mol. Med. Vol. 44(5), 330-339, 2012
genes by PRP treatment in the preadipocytes. The 
identified characteristics of PRP with regard to the 
preadipocytes have advantages including increases 
in the cell number and improved cell survival in the 
transplanted grafts. Together with our findings for 
the efficacies of fibrin scaffold in transplantation of 
ccdPAs (Aoyagi et al., 2011), the use of PRP for 
cell preparation and implantation of fat tissues 
and/or propagated cells may provide the graft with 
stable long-term survival after auto-transplantation.
Methods
Cell culture
Subcutaneous adipose tissues were obtained from healthy 
donors after informed consent was obtained, with approval 
from the ethics committee of Chiba University School of 
Medicine, and all studies were performed according to the 
guidelines of the Declaration of Helsinki. The preparation of 
the ceiling culture-derived proliferative adipocytes (ccdPAs) 
was performed as described previously (Kuroda et al., 
2011). Dulbecco’s modified Eagle’s medium/F12-HAM 
(DMEM/HAM, Sigma-Aldrich, St. Louis, MO) supplemented 
with 20% fetal bovine serum (FBS, SAFC Biosciences, 
Lenexa, KS) and 40 μg/ml gentamicin (GENTACIN, Schering- 
Plough Co., Kenilworth, NJ) was used as the culture me-
dia, unless otherwise noted in the text.
Preparation of PRP
Human PRP and PPP were prepared from healthy donors 
as follows; 52 ml of blood was obtained from the donors 
and mixed with 8 ml of Anticoagulant Citrate Dextrose 
Solution Formula A (ACD-A, TERUMO, Tokyo, Japan) sol-
ution, and transferred to 15 ml tubes. The tubes were cen-
trifuged at 300 × g for 15 min at 20
oC. The plasma and the 
buffy coat below the plasma were collected and transferred 
to new tubes. Secondary centrifugation was performed at 
2000 × g for 15 min at 20
oC. The clear supernatant 
(plasma) was decanted off until 6 ml was left and the mid-
dle portion of supernatant (plasma) was taken to be used 
as PPP. Finally, the remaining supernatant including the 
buffy coat was taken to be used as PRP. The platelet num-
ber of each product was automatically measured (XS 800i, 
sysmex Japan). The PRP utilized in this study contained 
8.6 × 10
6 platelets/μl, which was approximately 7-fold con-
centrated from the original concentration in whole human 
plasma. Preparations of serum lysates containing plate-
let-released growth factors were essentially performed ac-
cording to the method described by Aiba-Kojima et al. 
(2007). In brief, 2 U/ml of thrombin (Astellas Pharma Inc. 
Tokyo, Japan) was added to PRP and PPP, and the sam-
ples were agitated for 1 hr at 37
oC and then incubated 
overnight at 4
oC. Platelet bodies and any remaining fibrin 
were eliminated by centrifugation (2000 × g for 10 min), 
and the supernatants were obtained for the PRP and PPP. 
The serum samples were frozen at -20
oC and thawed at 
37
oC before use. The growth medium was supplemented 
with 2 U/ml of heparin (Novo-Heparin, 5,000 units/5 ml for 
Injection, Mochida Pharm. Co. Tokyo, Japan).
Culture on fibrin scaffolds
Bolheal (The Chemo-Sero-Therapeutic Research Institute, 
Kumamoto, Japan) was used as a clinically available material 
to generate the fibrin gel. Fibrinogen and thrombin solutions 
were diluted with Ringer’s Solution (Fuso Pharmaceutical 
Industries, Osaka, Japan) containing 0.5% human serum 
albumin (Mitsubishi Tanabe Pharma., Tokyo, Japan). The 
ccdPAs were suspended at 1 × 10
7 cells/ml by the diluted 
fibrinogen and thrombin solution. The final concentration of 
fibrinogen was 4 mg/ml and the thrombin solution was 
used at 1 U/ml. To form fibrin clots, 50 μl of the cell-fibri-
nogen suspension was added to each cell culture insert 
(Falcon 3104; Becton Dickinson, Franklin Lakes, NJ), then 
shortly thereafter, 50 μl of the cell-thrombin suspension 
was added into the insert, mixed by pipetting, and in-
cubated at room temperature for 2 h. The inserts with fibrin 
clots were put on 12 well culture plates, and culture media 
were added to the inserts and wells. The plates were in-
cubated at 37
oC for 12 h in a 5% CO2 incubator, and the 
media were replaced by fresh media containing FBS or 
PRP.
LDH assay
LDH released into the culture supernatant from the FG/ccdPA 
was measured using the CytoTox-One Homogeneous 
Membrane Integrity Assay kit (Promega, Madison, WI). A 
100 μl sample of each culture supernatant was collected 
and added into to a 96-well plate. An equal volume of 
CytoTox-One Reagent was added and incubated for 10 
min. Fifty μl of Stop Solution was added and the sample 
fluorescence was measured on a fluorescence microplate 
reader (SPECTRA max GEMINI XPS, Molecular Devices, 
Carlsbad, CA) using a wavelength of 560 nm/590 nm for 
excitation/emission. The original culture medium before the 
serum concentration was changed served as a pre-treat-
ment control sample and the control value was subtracted 
from the value obtained after incubation with the medium 
containing different concentrations of serum.
Cell proliferation assay
The cell proliferation was examined using the CyQUANT
R 
Cell Proliferation Assay Kit (Life Technologies, Carlsbad, 
CA). Cells were seeded into 96 well plates at a density of 2
× 10
3 cells per well with DMEM/HAM/20% FBS. After 24 
h, the culture medium was removed and changed to fresh 
DMEM/HAM without serum, or with FBS, PRP or PPP. 
After 3 days, the microplates were gently inverted and blot-
ted onto paper towels to remove the medium from the 
wells. The microplates were then frozen and stored at 
-80
oC and thawed at room temperature prior to analysis. 
CyQUANT GR dye/cell-lysis buffer was added to each well. 
Cells were incubated at room temperature for 5 min and 
the sample fluorescence was measured on a fluorescence 
microplate reader (SPECTRA max GEMINI XPS, Molecular 
Devices) using wavelength of 480 nm/520 nm for excitation/ 
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Induction of apoptosis, and the annexin V binding 
and caspase 3 activity assays
The cells were seeded into 10 cm dishes at a density of 1 ×
10
6 cells per well with DMEM/HAM/20%FBS. After 24 h, 
the culture medium was removed and changed to fresh 
DMEM/HAM with 2% FBS, 2% PRP or 2%PPP. After 2 h, 
apoptosis was induced by the addition of 100 ng/ml TNF-α 
(Peprotech, Rocky Hill, NJ) and 100 μg/ml cycloheximide 
(CHX, Sigma-Aldrich). After 3 h, the culture supernatant 
was collected, and the cells were detached by TrypZean 
treatment. The detached cells were suspended in the col-
lected culture supernatant. Subsequently, the cells were 
stained with Annexin V-FITC using a Tali
TM Apoptosis kit 
(Life Technologies). Stained cells were analyzed by a 
Tali
TM Image Based Cytometer (Life technologies). Cell ly-
sates at the concentration of 1 × 10
4 cells/μl were pre-
pared from the cells treated to induce apoptosis, and the 
caspase 3 activity levels were measured by a cas-
pase-3/CPP32 Fluorometric Assay Kit (Biovision, Mountain 
View, CA). To examine the phosphorylation status of 
ERK1/2, the cells were scraped off at each time point in 
PBS and washed. The cells were pelleted and lysed by 
RIPA buffer (Wako Pure Chemical Industries, Ltd. Osaka, 
Japan), and the protein concentration was determined by 
Quant-iT Protein Assay Kit (Life technologies), and 5 μg of 
protein were analyzed by Western blotting using anti-ERK1 
and anti-ERK1/2 (pT202/pY204) as primary antibodies (BD 
Biosciences, Franklin Lakes, NJ). Mouse TrueBlot ULTRA 
HRP-conjugated Anti-Mouse IgG (eBioscience, Inc. San 
Diego, CA) was used as a secondary antibody, and the sig-
nals were detected by SuperSignal
Ⓡ West Femto Maximum 
Sensitivity Substrate (Thermo Fisher Scientific Inc.) with 
LAS1000 apparatus (FUJI film, Tokyo, Japan). ERK signals 
were normalized using Actin signals detected by Anti-Actin 
monoclonal antibody (clone AC-40, Sigma-Aldrich).
Gene expression analysis
Cells (2.5 × 10
5 cells) were seeded into 10 cm dish with 
DMEM/HAM/20% FBS and cultured for 16 h. The culture 
medium was changed to fresh DMEM/HAM supplemented 
with 2% FBS or 2% PRP, and the cells were further in-
cubated for 72 h. The total RNA from cultured cells was ex-
tracted using a RT
2 RNA Isolation Kit (SA Bioscience, 
Frederick, MD). Complementary DNA was generated from 
1  μg of total RNA using the RT
2 First Strand Kit. An 
Apoptosis Reverse Transcriptase RT
2 profiler PCR array 
and RT
2 Real-Time SYBR Green/ROX PCR Mix (SA 
Bioscience, Frederick, MD) were used to identify the genes 
affected by PRP according to manufacturer’s instruction. 
The data were analyzed by web-based data analysis soft-
ware provided by the manufacturer. The probe and primer 
sets used to quantify the mRNA for the DAPK1 and BIM 
genes were purchased from Applied Biosystems (Life 
Technologies). The quantification of given genes was ex-
pressed as the relative mRNA level compared with a con-
trol after normalization to 18S RNA. All the real-time PCR 
were performed using an ABI 7500 real-time PCR apparatus.
Statistical analysis
The data are presented as the means ± S.D. Statistical 
comparisons were made by Student’s t-test or an ANOVA 
followed by the post-hoc Tukey test using the SPSS soft-
ware program. In all cases, P-values ＜ 0.05 were consid-
ered to be significant.
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